Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Individually Targeted Neuromodulation for Contamination-based Obsessive-compulsive Disorder

NCT05048251 is registered in ClinicalTrials.gov with Mclean Hospital as lead sponsor.

NCT NCT05048251
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05048251 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Individually Targeted Neuromodulation for Contamination-based Obsessive-compulsive Disorder
Lead sponsor
Mclean Hospital
Phase
Not applicable
Overall status
Recruiting
Start date
July 1, 2022
Completion date
June 30, 2024
Enrollment
50 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

obsessive-compulsive disorder